Cel Sci Corp
CVM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000725363
In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Cel Sci Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 61 | 66 | +5 |
| Shares | 5.49M | 5.43M | −66.9K (−1.2%) |
| Value | $13.2M | $6.79M | −$6.45M (−48.7%) |
New holders (8)
Institutions that held Cel Sci Corp at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Thoroughbred Financial Services, LLC | 101,761 | $127.0K | 0.01% |
| Sonic GP LLC | 100,000 | $125.0K | 0.12% |
| Two Sigma Securities, LLC | 19,970 | $25.0K | 0.00% |
| Calton & Associates, Inc. | 19,300 | $24.1K | 0.04% |
| Retirement Group, LLC | 1,420 | $1.77K | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 211 | $264 | 0.00% |
| Qube Research & Technologies Ltd | 2 | $3 | 0.00% |
| NBC Securities, Inc. | 19 | $0 | 0.00% |
Sold out (3)
Institutions that held Cel Sci Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Gsa Capital Partners LLP | 85,904 | $207.0K |
| Mariner, LLC | 16,240 | $39.1K |
| FMR LLC | 663 | $1.60K |